Analystreport

ZEALAND PHARMA/S (NASDAQ: ZEAL) was upgraded by analysts at Goldman Sachs Group Inc from a "neutral" rating to a "buy" rating.

Zealand Pharma A/S - American Depositary Shares  (ZEAL) 
Last zealand pharma a/s - american depositary shares earnings: 11/15 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: zealandpharma.com